SCHEMBL1286738

SCHEMBL1286738

CC(C)(C)CNC(=O)Nc1c[nH]nc1C(=O)NC1CCC(O)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.35
TRPV1 Q8NER1 3/20 0.34
BUB1 O43683 1/20 0.34
CYP2C9 P11712 1/20 0.34
PRKACG P22612 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
MAPK11 Q15759 1/20 0.34
MAPK14 Q16539 1/20 0.34
ACSL5 Q9ULC5 1/20 0.34
STK24 Q9Y6E0 1/20 0.34
CD38 P28907 3/20 0.34
ALDH1A1 P00352 2/20 0.34
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
BRD4 O60885 1/20 0.34
ACVR1 Q04771 1/20 0.33
EPHX2 P34913 1/20 0.33
HPGDS O60760 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8222280 1.00 L3MBTL1 (0.35) L3MBTL1TRPV1BUB1CYP2C9PRKACG
SCHEMBL12062383 0.84 BRD4 (0.35) L3MBTL1TRPV1CD38ALDH1A1CDK1
SCHEMBL12000436 0.81 EPHX1 (0.46) L3MBTL1ALDH1A1BRD4KDM4EPOLB
SCHEMBL8220657 0.81 EPHX1 (0.46) L3MBTL1ALDH1A1BRD4KDM4EPOLB
SCHEMBL8215065 0.79 DYRK1A (0.41) ALDH1A1EPHX2PKMKDM4ELMNA
SCHEMBL1286744 0.79 DYRK1A (0.41) ALDH1A1EPHX2PKMKDM4ELMNA
SCHEMBL8262291 0.79 F2 (0.39) TRPV1CD38CDK1CCNB1CCNA2
SCHEMBL8212906 0.78 EPHX2 (0.44) L3MBTL1ALDH1A1CDK1CCNB1CCNA2
SCHEMBL8216567 0.78 EPHX2 (0.44) L3MBTL1ALDH1A1CDK1CCNB1CCNA2
SCHEMBL1286712 0.75 CDK1 (0.48) L3MBTL1TRPV1CDK1CCNB1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651612-B9 3,4-DISUBSTITUTED 1H-PYRAZOLE COMPOUNDS AND THEIR USE AS CYCLIN DEPENDENT KINASES (CDK) AND GLYCOGEN SYNTHASE KINASE-3 (GSK-3) MODULATORS ASTEX THERAPEUTICS LTD (GB) 2012-09-05 EP disclosed
EP-1651612-B1 3,4-DISUBSTITUTED 1H-PYRAZOLE COMPOUNDS AND THEIR USE AS CYCLIN DEPENDENT KINASES (CDK) AND GLYCOGEN SYNTHASE KINASE-3 (GSK-3) MODULATORS ASTEX THERAPEUTICS LTD (GB) 2012-04-11 EP disclosed
EP-2256106-A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators Astex Therapeutics Limited (GB) 2010-12-01 EP disclosed
WO-2008007122-A2 COMBINATIONS OF PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDKS AND GSK'S ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed